News

Video

Dr Bazhenova on Potential Combination Strategies With KRAS G12C Inhibitors in Advanced NSCLC

Author(s):

Lyudmila A. Bazhenova, MD
Conference|International Lung Cancer Congress

Lyudmila A. Bazhenova, MD, discusses potential combination strategies with KRAS G12C inhibitors in advanced non–small cell lung cancer.

Lyudmila A. Bazhenova, MD, medical oncologist, professor of clinical medicine, University of California San Diego Moores Cancer Center, discusses potential combination strategies with KRAS G12C inhibitors in KRAS G12C–mutant advanced non–small cell lung cancer.

Related Videos
Rene Y. McNall-Knapp, MD, pediatric hematologist-oncologist, Jimmy Everest Center, Oklahoma Children’s Hospital OU Health; professor, Department of Pediatrics, University of Oklahoma Health Sciences Center
John Andrew Livingston, MD, MS
Howard Colman, MD, PhD, Jan M. Huntsman Presidential Professor, Department of Neurosurgery, member, Brain Tumor Research Team, and leader, Center for Neurologic Cancers, Huntsman Cancer Institute, University of Utah
Kathleen N. Moore, MD, MS
Rona Yaeger, MD
PER® International Symposium on Melanoma and Other Cutaneous Malignancies
Robert
Charles B. Nguyen, MD
YI LIN, MD, PHD
Dr Fakih on the FDA Approval of Sotorasib Plus Panitumumab for KRAS G12C–Mutated mCRC
Related Content
Vikram M. Narayan, MD, of Emory University Hospital
February 10th 2025

Bladder Cancer Care Shifts as BCG Shortage Lingers, With Investigative Combinations and Tools at the Forefront

MedNews Week
December 12th 2024

Delve Into Data With Amivantamab Plus Lazertinib in EGFR-Mutated NSCLC: With Chandler Park, MD; and Stephen Liu, MD

Encorafenib combination boosts survival in BRAF V600E+ mCRC, pertuzumab biosimilar BLA is under review for HER2+ breast cancer, and more from OncLive.
February 8th 2025

The OncFive: Top Oncology Articles for the Week of 2/2

Ongoing Research Advances Equity and Precision Oncology Through Tissue-Agnostic Therapies: With Chandler Park, MD, and Vivek Subbiah, MD
October 30th 2024

Ongoing Research Advances Equity and Precision Oncology Through Tissue-Agnostic Therapies: With Chandler Park, MD, and Vivek Subbiah, MD

ASCO GI | Image Credit: © Katsyarina – stock.adobe.com
February 7th 2025

Northwestern Medicine Performs the Highest Number of Lung Transplants in the United States

Acute Myeloid Leukemia | © Nittaya – stock.adobe.com
February 6th 2025

Ziftomenib Meets CR/CRh End Point in R/R NPM1+ AML